JP Morgan Maintains Neutral on Cardinal Health, Lowers Price Target to $215

Benzinga Newsdesk www.benzinga.com Negative 83.2%

Neg 83.2% Neu 0% Pos 0%

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and lowers the price target from $243 to $215.